Enanta

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Enanta and other ETFs, options, and stocks.

About ENTA

Enanta Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery and development of small molecule drugs for the treatment of viral infections and liver diseases. It produces clinical candidates which targets respiratory syncytial virus (RSV), hepatitis B virus (HBV), and non-alcoholic steatohepatitis (NASH) diseases. 

CEO
Jay R. Luly
CEOJay R. Luly
Employees
120
Employees120
Headquarters
Watertown, Massachusetts
HeadquartersWatertown, Massachusetts
Founded
1995
Founded1995
Employees
120
Employees120

ENTA Key Statistics

Market cap
479.99M
Market cap479.99M
Price-Earnings ratio
-4.32
Price-Earnings ratio-4.32
Dividend yield
Dividend yield
Average volume
467.08K
Average volume467.08K
High today
$17.05
High today$17.05
Low today
$15.84
Low today$15.84
Open price
$15.84
Open price$15.84
Volume
236.09K
Volume236.09K
52 Week high
$17.05
52 Week high$17.05
52 Week low
$4.09
52 Week low$4.09

Stock Snapshot

As of today, Enanta(ENTA) shares are valued at $16.60. The company's market cap stands at 479.99M, with a P/E ratio of -4.32.

As of 2025-12-25, Enanta(ENTA) stock has fluctuated between $15.84 and $17.05. The current price stands at $16.60, placing the stock +4.8% above today's low and -2.6% off the high.

Enanta(ENTA) shares are trading with a volume of 236.09K, against a daily average of 467.08K.

During the past year, Enanta(ENTA) stock moved between $4.09 at its lowest and $17.05 at its peak.

During the past year, Enanta(ENTA) stock moved between $4.09 at its lowest and $17.05 at its peak.

ENTA News

Simply Wall St 5d
Enanta Pharmaceuticals, Inc. Stock Catapults 27% Though Its Price And Business Still Lag The Industry

Despite an already strong run, Enanta Pharmaceuticals, Inc. ( ) shares have been powering on, with a gain of 27% in the last thirty days. The last month tops of...

Enanta Pharmaceuticals, Inc. Stock Catapults 27% Though Its Price And Business Still Lag The Industry

Analyst ratings

88%

of 8 ratings
Buy
87.5%
Hold
12.5%
Sell
0%

People also own

Based on the portfolios of people who own ENTA. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.